Keyphrases
Arterial Vessels
9%
Beta-blockers
9%
Constriction
100%
Cyclooxygenase-1 (COX-1)
18%
Cyclooxygenase-2
100%
Cyclooxygenase-2 Inhibitors
9%
Dilators
9%
Endothelial Function
9%
Ethidium Bromide
9%
Flow Effect
100%
Flow Shear Stress
18%
Gracilis muscle
9%
Hyperhomocysteinemia
100%
Indomethacin
9%
L-NAME
9%
Methionine Supplementation
9%
Nitric Oxide
9%
Nitric Oxide Synthase Inhibitors
9%
Non-selective
9%
NS-398
9%
Pathophysiological Mechanisms
9%
Prostaglandins
9%
Reactive Oxygen Species
100%
Reactive Oxygen Species Production
9%
Reversed Flow
9%
SC-560
9%
Simultaneous Administration
9%
Skeletal muscle
9%
Small Vein
9%
Stress Dependence
9%
Stress Increment
9%
Thrombosis
9%
Thromboxane A2 (TXA2)
100%
Thromboxane A2 Receptor
9%
Thrombus Formation
9%
TP Antagonist
9%
Vascular Resistance
9%
Vasomotor Tone
9%
Venules
100%
Medicine and Dentistry
Blood Clotting
9%
Cyclooxygenase 1 Inhibitor
9%
Cyclooxygenase 2
100%
Cyclooxygenase 2 Inhibitor
9%
Endothelial Function
9%
Ethidium Bromide
9%
Gracilis Muscle
9%
Hyperhomocysteinemia
100%
Indometacin
9%
Ligation
100%
Methionine
9%
Nitric Oxide
9%
Nitric Oxide Synthase Inhibitor
9%
Prostaglandin
9%
Prostaglandin Synthase
9%
Reactive Oxygen Species
100%
Skeletal Muscle
9%
Thrombosis
9%
Thromboxane A2
100%
Thromboxane A2 Receptor
9%
Vascular Resistance
9%
Vasomotor
9%
Venule
100%
Pharmacology, Toxicology and Pharmaceutical Science
COX-2 Inhibitor
9%
Cyclooxygenase 1 Inhibitor
9%
Cyclooxygenase 2
100%
Ethidium Bromide
9%
Hyperhomocysteinemia
100%
Indometacin
9%
Methionine
9%
Nitric Oxide
9%
Nitric Oxide Synthase Inhibitor
9%
NS-398
9%
Prostaglandin
9%
Prostaglandin Synthase
9%
Reactive Oxygen Metabolite
100%
Thrombosis
9%
Thromboxane A2
100%
Thromboxane A2 Receptor
9%
Thrombus
9%